First, the GC patients with a higher proportion of CD226+CD8+TILs had better OS than those with lower number of CD226+CD8+TILs (HR=0.5838, 95% CI: 0.3552-0.9598, P=0.0207, Figure 3A). This evidence concerns the gene CD226 and gastric cancer.